Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.2B | 1.2B | 1.2B |
Cost of revenue | 679M | 721M | 736M | 722M |
Gross profit | 475M | 490M | 465M | 458M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 280M | 277M | 267M | 275M |
Other operating expenses | 74M | 59M | 82M | 71M |
Operating income | 52M | 78M | 46M | 43M |
Non operating interest income | ||||
Income | — | — | 1M | — |
Expense | 35M | 33M | 35M | 35M |
Other income expense | 1M | -56M | -6M | -4M |
Pretax income | 17M | -13M | 5M | 3M |
Tax provision | 5M | -6M | -1M | -1M |
Net income | 12M | -7M | 6M | 4M |
Basic EPS | 0.1 | -0.1 | 0.0 | 0.0 |
Diluted EPS | 0.1 | -0.1 | 0.0 | 0.0 |
Basic average shares | 101.0M | 101.0M | 101.0M | 100.8M |
Diluted average shares | 101.4M | 101.3M | 101.0M | 100.9M |
EBITDA | 123M | 157M | 121M | 117M |
Net income from continuing op. | 7M | -13M | 1M | 1M |
Minority interests | -5M | -6M | -5M | -3M |
Preferred stock dividends | — | — | — | — |